compulsory licensing

This page shows the latest compulsory licensing news and features for those working in and with pharma, biotech and healthcare.

Roche blocks Herceptin biosimilar in India

Herceptin has been an intellectual property (IP) battleground in India, with threats of compulsory licensing eventually causing Roche to relinquish its patents on the drug in India, clearing the path for

Latest news

Pharma slammed for undermining South African IP reforms

life-saving medicines through compulsory licensing and other means. .
Biocon plans February launch for first biosimilar Herceptin

It has been suggested the company took the decision after it emerged it was facing compulsory licensing for Herceptin in India on the grounds of public need, a path which opened
Pharma should not ignore India

It’s complicated, but multinational pharma cannot ignore a market with one billion plus people
Roche loses Herceptin patents in India

Compulsory licensing threat looms. A much bigger threat to Herceptin in India is that of compulsory licensing, which was used to clear the path for low-cost versions of Bayer's ... There was some positive news for Roche last month after India's
Pharma waits for Glivec patent verdict in India

Meanwhile, other patented medicines have been subject to compulsory licensing in India on the principle of public health need.

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

Stress testing for the perfect compliance storm

Some markets have introduced charges for access to state healthcare premises or compulsory licensing, and some HCOs are now seeking direct support either as financial donations or as medical education, patient
Intellectual property threats in the BRIC markets

However, China also passed the “Measures for the Compulsory Licensing of Patent Implementation” law in May 2012. ... There are two ways of interpreting recent trends in compulsory licensing and IP loss.
Building BRICs: pharma's key emerging markets are becoming giants

Others, such as Roche, are partnering with local manufacturers under out-licensing agreements. ... The government has issued high-profile proposals around compulsory licensing and price-capping.

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Associate Director: £75, 000-90, 000

Account Manager / Senior Account Manager: 35, 000-40, 000

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Director – Healthcare Marketing – Berks: Salary TBC

Medical Writer: Salary TBC

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Director, Medical Education: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Global Business Development Director – Health Education: excellent commission

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Manager: Competitive Salary Offered

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Director: Competitive Salary Offered

Business Director: Competitive Salary Offered

Account Manager / Account Director: Competative

Account Director – Health Policy – Global Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

NHS regional footprints: What to expect from 2019...
Not another weight-loss ad: Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...